Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Farmers Insurance
Covington
Daiichi Sankyo
Baxter
Colorcon
Teva
Fuji

Generated: November 12, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for SUVN-502

« Back to Dashboard

US Patents for SUVN-502

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SUVN-502 ➤ Sign Up Tetracyclic 3-substituted indoles having serotonin receptor affinity Suven Life Sciences Limited (Hyderabad, Adhra Pradesh, IN) ➤ Sign Up
SUVN-502 ➤ Sign Up N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them Suven Life Sciences Limited (IN) ➤ Sign Up
SUVN-502 ➤ Sign Up Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-- 1H-indole dimesylate monohydrate SUVEN LIFE SCIENCES LIMITED (Hyderbad, IN) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for SUVN-502

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
SUVN-502 Austria 355292 1989-12-31 ➤ Sign Up
SUVN-502 Australia 2003292510 1989-12-31 ➤ Sign Up
SUVN-502 Brazil 0316895 1989-12-31 ➤ Sign Up
SUVN-502 Canada 2507923 1989-12-31 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
McKinsey
Dow
Fuji
Cipla
US Department of Justice
Healthtrust
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: